ABG-WTT Global Life Science Capital Partners GP Ltd — Q2 2021 13F Holdings

Name: ABG-WTT Global Life Science Capital Partners GP Ltd — 13F Holdings, Q2 2021
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001832108

Total reported value

$12.3M

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	MYOSUSD	Medavail Holdings INC	Stock-Other	92.00%	—	—
2	LUNG	Pulmonx CORP	Stock-Other	8.00%	—	-88.49%

Position changes disclosed by ABG-WTT Global Life Science Capital Partners GP Ltd for the quarter ending Q2 2021, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	MYOSUSD	Medavail Holdings INC	—	EXIT	Sold out
2	LUNG	Pulmonx CORP	—	EXIT	Sold out